Proprietary ELISA reagents for early detection of neurodegenerative markers associated with Alzheimer's disease and age-related cognitive decline. This patented series represents the first domestically-developed solution for dementia biomarker detection.
Manufactured by
China
Shenzhen Anqun Biotech Co., Ltd., established in 1994, is a national high-tech enterprise specializing in R&D and manufacturing of in-vitro diagnostic reagents. The company holds 53 product registration certificates covering ELISA reagents in 9 series including infertility, respiratory diseases, and early Alzheimer's screening. Anqun maintains 16 granted invention patents and collaborates with leading universities including Sun Yat-sen University and Capital Medical University.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
shanghai rendu biotechnology co.,ltd.
China · 1 relevant product
AssureTech.(Hangzhou) Co.,Ltd.
China · 1 relevant product
Randox Laboratories Ltd.
United Kingdom · 1 relevant product
Origin Biotechnology Co., Ltd.
Taiwan · 1 relevant product
National Reference Laboratory
United Arab Emirates · 4 relevant products
Ailex Technology Group Co.,Ltd
China · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
Beckman Coulter
United States · 1 relevant product
Shaoxing Shouren Medical Health & Technology Co., Ltd.
China · 1 relevant product
ADmit Therapeutics SL
Spain · 2 relevant products
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 80 closest product alternatives
shanghai rendu biotechnology co.,ltd. · China
Molecular diagnostic reagents designed for early detection of cancer-related RNA biomarkers. These products facilitate early cancer detection and risk stratification through precision molecular testing.
AssureTech.(Hangzhou) Co.,Ltd. · China
A series of diagnostic tests designed for the detection and monitoring of chronic diseases. These products enable rapid assessment of chronic disease biomarkers.
Randox Laboratories Ltd. · United Kingdom
Biomarker tests and diagnostic solutions for Alzheimer's disease assessment. These products support early detection and monitoring of neurodegenerative disease.
Origin Biotechnology Co., Ltd. · Taiwan
A diagnostic test for the assessment and diagnosis of dementia in elderly patients using molecular biomarkers.
National Reference Laboratory · United Arab Emirates
Precision biomarker testing for early detection and monitoring of Alzheimer's disease and other dementias. This specialized service enables early intervention and prevention strategies for neurodegenerative conditions.
Ailex Technology Group Co.,Ltd · China
A dual-use reagent kit for home self-testing and clinical detection of Alzheimer's disease using immunochromatographic methods. The kit is designed for auxiliary diagnosis purposes in both clinical and home settings.
BioChain (Beijing) Science & Technology. Inc. · China
Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.
Beckman Coulter · United States
High-sensitivity assays for detection of neurological disease biomarkers including GFAP, NfL, APOE ε4, and pTau-217.
Shaoxing Shouren Medical Health & Technology Co., Ltd. · China
Blood biomarker test for Alzheimer's Disease detection and diagnosis. Utilizes advanced analytical methods to measure disease-specific protein markers in patient serum samples. Supports early disease identification and clinical assessment of neurodegenerative status.
ADmit Therapeutics SL · Spain
An early detection diagnostic test designed for clinical practice to identify Alzheimer's disease at preliminary stages. The test utilizes proprietary technology to support early diagnosis and patient management in clinical settings.
EUROIMMUN · United States
Diagnostic tests for detection of biomarkers associated with neurodegenerative diseases including Alzheimer's and Parkinson's disease. These tests support early identification and monitoring of neurological decline in patient populations.
Lansion Biotechnology Co., Ltd. · China
Dry fluorescence immunoassay test kit for Alzheimer disease-associated protein detection. Enables rapid neurodegenerative disease screening.
68 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products